Literature DB >> 22907435

Decreased eIF3e/Int6 expression causes epithelial-to-mesenchymal transition in breast epithelial cells.

L D Gillis1, S M Lewis.   

Abstract

eIF3e/Int6 is a component of the multi-subunit eIF3 complex, which binds directly to the 40S ribosome to facilitate ribosome recruitment to mRNA and hence protein synthesis. Reduced expression of eIF3e/Int6 has been found in up to 37% of human breast cancers, and expression of a truncated mutant version of the mouse eIF3e/Int6 protein leads to malignant transformation of normal mammary cells. These findings suggest that eIF3e/Int6 is a tumor suppressor; however, a recent study has reported that a reduction of eIF3e/Int6 expression in breast cancer cells leads to reduced translation of oncogenes, suggesting that eIF3e/Int6 may in fact have an oncogenic role in breast cancer. To gain a better understanding of the role of eIF3e/Int6 in breast cancer, we have examined the effects of decreased eIF3e/Int6 expression in an immortalized breast epithelial cell line, MCF-10A. Surprisingly, we find that decreased expression of eIF3e/Int6 causes breast epithelial cells to undergo epithelial-to-mesenchymal transition (EMT). We show that EMT induced by a decrease in eIF3e/Int6 expression imparts invasive and migratory properties to breast epithelial cells, suggesting that regulation of EMT by eIF3e/Int6 may have an important role in breast cancer metastasis. Furthermore, we show that reduced eIF3e/Int6 expression in breast epithelial cells causes a specific increase in the expression of the key EMT regulators Snail1 and Zeb2, which occurs at both the transcriptional and post-transcriptional levels. Together, our data indicate a novel role of eIF3e/Int6 in the regulation of EMT in breast epithelial cells and support a tumor suppressor role of eIF3e/Int6.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22907435     DOI: 10.1038/onc.2012.371

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  A Transcript-Specific eIF3 Complex Mediates Global Translational Control of Energy Metabolism.

Authors:  Meera Shah; Dan Su; Judith S Scheliga; Tomáš Pluskal; Susanna Boronat; Khatereh Motamedchaboki; Alexandre Rosa Campos; Feng Qi; Elena Hidalgo; Mitsuhiro Yanagida; Dieter A Wolf
Journal:  Cell Rep       Date:  2016-07-28       Impact factor: 9.423

2.  INT6/EIF3E Controls the RNF8-Dependent Ubiquitylation Pathway and Facilitates DNA Double-Strand Break Repair in Human Cells.

Authors:  Christelle Morris; Nozomi Tomimatsu; Sandeep Burma; Pierre Jalinot
Journal:  Cancer Res       Date:  2016-08-22       Impact factor: 12.701

3.  A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis.

Authors:  Annelise Carvalho; Jennifer Chu; Céline Meinguet; Robert Kiss; Guy Vandenbussche; Bernard Masereel; Johan Wouters; Alexander Kornienko; Jerry Pelletier; Véronique Mathieu
Journal:  Eur J Pharmacol       Date:  2017-03-18       Impact factor: 4.432

4.  Assembly of eIF3 Mediated by Mutually Dependent Subunit Insertion.

Authors:  M Duane Smith; Luisa Arake-Tacca; Adam Nitido; Elizabeth Montabana; Annsea Park; Jamie H Cate
Journal:  Structure       Date:  2016-05-19       Impact factor: 5.006

5.  Haploinsufficient tumor suppressor PRP4K is negatively regulated during epithelial-to-mesenchymal transition.

Authors:  Livia E Clarke; Allyson Cook; Sabateeshan Mathavarajah; Amit Bera; Jayme Salsman; Elias Habib; Carter Van Iderstine; Moamen Bydoun; Stephen M Lewis; Graham Dellaire
Journal:  FASEB J       Date:  2021-11       Impact factor: 5.834

6.  Int6/eIF3e is essential for proliferation and survival of human glioblastoma cells.

Authors:  Julie Sesen; Anne Cammas; Sarah J Scotland; Bertand Elefterion; Anthony Lemarié; Stefania Millevoi; Lijoy K Mathew; Cathy Seva; Christine Toulas; Elizabeth Cohen-Jonathan Moyal; Nicolas Skuli
Journal:  Int J Mol Sci       Date:  2014-01-29       Impact factor: 5.923

7.  Int6 reduction activates stromal fibroblasts to enhance transforming activity in breast epithelial cells.

Authors:  Jinfeng Suo; Daniel Medina; Sabrina Herrera; Ze-Yi Zheng; Lei Jin; Gary C Chamness; Alejandro Contreras; Carolina Gutierrez; Susan Hilsenbeck; Arzu Umar; John A Foekens; Samir Hanash; Rachel Schiff; Xiang H-F Zhang; Eric C Chang
Journal:  Cell Biosci       Date:  2015-03-08       Impact factor: 7.133

8.  Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma.

Authors:  Caixia Cheng; Yong Zhou; Hongyi Li; Teng Xiong; Shuaicheng Li; Yanghui Bi; Pengzhou Kong; Fang Wang; Heyang Cui; Yaoping Li; Xiaodong Fang; Ting Yan; Yike Li; Juan Wang; Bin Yang; Ling Zhang; Zhiwu Jia; Bin Song; Xiaoling Hu; Jie Yang; Haile Qiu; Gehong Zhang; Jing Liu; Enwei Xu; Ruyi Shi; Yanyan Zhang; Haiyan Liu; Chanting He; Zhenxiang Zhao; Yu Qian; Ruizhou Rong; Zhiwei Han; Yanlin Zhang; Wen Luo; Jiaqian Wang; Shaoliang Peng; Xukui Yang; Xiangchun Li; Lin Li; Hu Fang; Xingmin Liu; Li Ma; Yunqing Chen; Shiping Guo; Xing Chen; Yanfeng Xi; Guodong Li; Jianfang Liang; Xiaofeng Yang; Jiansheng Guo; JunMei Jia; Qingshan Li; Xiaolong Cheng; Qimin Zhan; Yongping Cui
Journal:  Am J Hum Genet       Date:  2016-01-28       Impact factor: 11.025

9.  The effect of heterogeneous Transcription Start Sites (TSS) on the translatome: implications for the mammalian cellular phenotype.

Authors:  Francois-Xavier Dieudonné; Patrick B F O'Connor; Pascale Gubler-Jaquier; Haleh Yasrebi; Beatrice Conne; Sergey Nikolaev; Stylianos Antonarakis; Pavel V Baranov; Joseph Curran
Journal:  BMC Genomics       Date:  2015-11-21       Impact factor: 3.969

Review 10.  Targeting translation initiation in breast cancer.

Authors:  Argun Akcakanat; David S Hong; Funda Meric-Bernstam
Journal:  Translation (Austin)       Date:  2014-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.